404 related articles for article (PubMed ID: 27059958)
1. Structural Determinants of Binding the Seven-transmembrane Domain of the Glucagon-like Peptide-1 Receptor (GLP-1R).
Yang D; de Graaf C; Yang L; Song G; Dai A; Cai X; Feng Y; Reedtz-Runge S; Hanson MA; Yang H; Jiang H; Stevens RC; Wang MW
J Biol Chem; 2016 Jun; 291(25):12991-3004. PubMed ID: 27059958
[TBL] [Abstract][Full Text] [Related]
2. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
3. 7TM Domain Structure of Adhesion GPCRs.
de Graaf C; Nijmeijer S; Wolf S; Ernst OP
Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of GLP-1R peptide agonist engagement are correlated with kinetics of G protein activation.
Deganutti G; Liang YL; Zhang X; Khoshouei M; Clydesdale L; Belousoff MJ; Venugopal H; Truong TT; Glukhova A; Keller AN; Gregory KJ; Leach K; Christopoulos A; Danev R; Reynolds CA; Zhao P; Sexton PM; Wootten D
Nat Commun; 2022 Jan; 13(1):92. PubMed ID: 35013280
[TBL] [Abstract][Full Text] [Related]
5. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
6. Design and preparation of the class B G protein-coupled receptors GLP-1R and GCGR for
Wang H; Hu W; Liu D; Wüthrich K
FEBS J; 2021 Jul; 288(13):4053-4063. PubMed ID: 33369025
[TBL] [Abstract][Full Text] [Related]
7. Investigation of ECD conformational transition mechanism of GLP-1R by molecular dynamics simulations and Markov state model.
Zhang J; Bai Q; Pérez-Sánchez H; Shang S; An X; Yao X
Phys Chem Chem Phys; 2019 Apr; 21(16):8470-8481. PubMed ID: 30957116
[TBL] [Abstract][Full Text] [Related]
8. The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling.
Dods RL; Donnelly D
Biosci Rep; 2015 Nov; 36(1):e00285. PubMed ID: 26598711
[TBL] [Abstract][Full Text] [Related]
9. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
[TBL] [Abstract][Full Text] [Related]
10. Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1.
Hager MV; Clydesdale L; Gellman SH; Sexton PM; Wootten D
Biochem Pharmacol; 2017 Jul; 136():99-108. PubMed ID: 28363772
[TBL] [Abstract][Full Text] [Related]
11. Genetically encoded photocross-linkers determine the biological binding site of exendin-4 peptide in the N-terminal domain of the intact human glucagon-like peptide-1 receptor (GLP-1R).
Koole C; Reynolds CA; Mobarec JC; Hick C; Sexton PM; Sakmar TP
J Biol Chem; 2017 Apr; 292(17):7131-7144. PubMed ID: 28283573
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor.
Underwood CR; Garibay P; Knudsen LB; Hastrup S; Peters GH; Rudolph R; Reedtz-Runge S
J Biol Chem; 2010 Jan; 285(1):723-30. PubMed ID: 19861722
[TBL] [Abstract][Full Text] [Related]
13. Functional consequences of glucagon-like peptide-1 receptor cross-talk and trafficking.
Roed SN; Nøhr AC; Wismann P; Iversen H; Bräuner-Osborne H; Knudsen SM; Waldhoer M
J Biol Chem; 2015 Jan; 290(2):1233-43. PubMed ID: 25451942
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics.
Gómez Santiago C; Paci E; Donnelly D
Biochem Biophys Res Commun; 2018 Mar; 498(2):359-365. PubMed ID: 29397068
[TBL] [Abstract][Full Text] [Related]
15. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain.
Runge S; Schimmer S; Oschmann J; Schiødt CB; Knudsen SM; Jeppesen CB; Madsen K; Lau J; Thøgersen H; Rudolph R
Biochemistry; 2007 May; 46(19):5830-40. PubMed ID: 17444618
[TBL] [Abstract][Full Text] [Related]
16. Two distinct domains of the glucagon-like peptide-1 receptor control peptide-mediated biased agonism.
Lei S; Clydesdale L; Dai A; Cai X; Feng Y; Yang D; Liang YL; Koole C; Zhao P; Coudrat T; Christopoulos A; Wang MW; Wootten D; Sexton PM
J Biol Chem; 2018 Jun; 293(24):9370-9387. PubMed ID: 29717000
[TBL] [Abstract][Full Text] [Related]
17. Ligand binding pocket formed by evolutionarily conserved residues in the glucagon-like peptide-1 (GLP-1) receptor core domain.
Moon MJ; Lee YN; Park S; Reyes-Alcaraz A; Hwang JI; Millar RP; Choe H; Seong JY
J Biol Chem; 2015 Feb; 290(9):5696-706. PubMed ID: 25561730
[TBL] [Abstract][Full Text] [Related]
18. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
Nakane A; Gotoh Y; Ichihara J; Nagata H
Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
[TBL] [Abstract][Full Text] [Related]
19. Allosteric Modulators Enhancing GLP-1 Binding to GLP-1R via a Transmembrane Site.
Wang J; Yang D; Cheng X; Yang L; Wang Z; Dai A; Cai X; Zhang C; Yuliantie E; Liu Q; Jiang H; Liu H; Wang MW; Yang H
ACS Chem Biol; 2021 Nov; 16(11):2444-2452. PubMed ID: 34570476
[TBL] [Abstract][Full Text] [Related]
20. Structural Mapping and Functional Characterization of Zebrafish Class B G-Protein Coupled Receptor (GPCR) with Dual Ligand Selectivity towards GLP-1 and Glucagon.
Oren DA; Wei Y; Skrabanek L; Chow BK; Mommsen T; Mojsov S
PLoS One; 2016; 11(12):e0167718. PubMed ID: 27930690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]